Authors : Dr.Kalpana Poudel; Dr. Gopa Kumar R. Nair; Dr. Saroj Poudel; Dr. Saroj Pokhrel; Dr. Jyoti Gupta; Dr. Rekha Poudel; Dr. Krishna Gopal Sharma; Dr. Kushdeeep Kumar Gupta
Volume/Issue : Volume 8 - 2023, Issue 2 - February
Google Scholar : https://bit.ly/3IIfn9N
Scribd : https://bit.ly/3mfmbWO
DOI : https://doi.org/10.5281/zenodo.7691927
- With the surge of cases during the third wave
of COVID-19, India faced a number of Mucormycosis
cases, a rare but potentially fatal fungal infection, caused
by the mucormycetes. The increased prevalence of
Mucormycosis among COVID-19 patients may be
associated with increased use of steroids, or the possible
immunocompromised state caused by SARS-CoV2 or coexisting conditions such as diabetes mellitus. Presenting
a case of Rhinomaxillary Mucormycosis where patient
presented with a complaint of ulcerative lesion on palate.
A diagnosis of Mucormycosis was established after
Contrast Enhanced Computed Tomography (CECT)
and cytology. Management was planned with antifungal
therapy and surgical intervention. Due to
immunocompromised state patient couldn’t survive
Keywords : COVID-19, Mucormycosis, Immunocomprised, Diabetes.